Jin Medical International Ltd. (NASDAQ:ZJYL) Sees Significant Decline in Short Interest

Jin Medical International Ltd. (NASDAQ:ZJYLGet Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totaling 79,215 shares, a decrease of 63.6% from the December 15th total of 217,828 shares. Based on an average daily volume of 153,591 shares, the short-interest ratio is presently 0.5 days. Approximately 0.1% of the company’s stock are short sold. Approximately 0.1% of the company’s stock are short sold. Based on an average daily volume of 153,591 shares, the short-interest ratio is presently 0.5 days.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Jin Medical International from a “sell (d)” rating to a “hold (c-)” rating in a research note on Monday, December 29th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Jin Medical International

Jin Medical International Stock Performance

ZJYL opened at $0.24 on Wednesday. Jin Medical International has a fifty-two week low of $0.18 and a fifty-two week high of $1.12. The firm has a 50-day moving average of $0.24 and a 200 day moving average of $0.45.

Jin Medical International Company Profile

(Get Free Report)

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

Further Reading

Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.